chrisvoncsefalvay/vaers-outcomes huggingface dataset:
fever between 100.2 and 102.3; Aches; This is a spontaneous report from a non-contactable consumer (patient).  A 77-years-old female non-pregnant patient received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 18Feb2021 (at the age of 77-years-old) (Lot Number: EL9264) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included Cancer, bi-polar (bipolar disorder), hypothroid, stage 3 kidney disease, allergies to Aspirin and penicillian, all from an unknown date and unknown if ongoing. Concomitant medications included levothyroxine sodium (SYNTHROID) and semisodium (DEPAKOTE) taken for an unspecified indication, start and stop date were not reported. Patient previously took first dose of BNT162B2 (lot number: EL8982, vaccine location: Left arm) on 28Jan2021 for covid-19 immunisation. It was reported that the patient experienced that fever between 100.2 and 102.3 and aches on 19Feb2021. Patient did not receive any treatment. Prior and post vaccination patient did not tested for covid. The outcome of all the events was recovering.  No follow-up attempts are possible. No further information is expected.
The night of getting my booster shot, I woke up with tightness in my chest and shortness of breath that led to having to use an inhaler. The tightness in chest and shortness of breath and using inhaler lasted several days after. I also ended up with a cough that I've continued to have since, fatigue and not feeling normal. On 11/16/21, I went to a walk in because the cough felt worse and having to use inhaler. The dr said I had crackling in my lower lungs, took x rays and it shows I have findings of Covid 19 pneumonia versus bibasilar atelectasis. I've tested negative for Covid. Now, I'm on two inhalers, cough medicine, antibiotics. This all started after the booster shot and has progressively gotten worse.
sick; fever; body aches; This case was reported by a consumer via call center representative and described the occurrence of sickness in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced sickness, fever and general body pain. On an unknown date, the outcome of the sickness, fever and general body pain were recovered/resolved.   It was unknown if the reporter considered the sickness, fever and general body pain to be related to Shingrix.     Additional Information: GSK Receipt Date: 7-APR-2022 Reporter's Comment: The patient self-reported this case. The patient received dose of Shingles vaccine and felt sick with fever and body aches for a week. The patient asked what could he/she do to help with the symptoms. The reporter did not consent to follow-up. Additional supportive information: This case was reported by a consumer via digital media.
EVERY SYMPTOM KNOWN TO MAN (EXCEPT FOR FULL BODY RASH); This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient was healthy and had not been sick for least 15 plus years. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 02-AUG-2021 for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch number. No concomitant medications were reported. On 02-AUG-2021, the subject experienced every symptom known to man (except for full body rash). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of every symptom known to man (except for full body rash) was not reported. This report was non-serious.
Information has been received from a physician via pediatric medical records concerning a 10 day old female with no known drug allergies who on 13-JUN-2008 was vaccinated with the first dose of RECOMBIVAX HB vaccine and on 13-AUG-2008 was vaccinated with the second dose of RECOMBIVAX HB vaccine. On 13-AUG-2008, the patient was also vaccinated with diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid, pneumococcal vaccine (unspecified), poliovirus vaccine inactivated (unspecified) and rotavirus G1 G2 G3 P1 reassortant vaccine live (human-bovine) (manufacturer unknown). On 29-OCT-2008 the patient was vaccinated with diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid, pneumococcal vaccine (unspecified), Hib conj vaccine (CMPC) (manufacturer unknown), poliovirus vaccine inactivated (unspecified) and rotavirus G1 G2 G3 G4 P1 reassortant vaccine live (human-bovine) (manufacturer unknown). On 16-JUN-2008 the patient's total bilirubin was noted to be 1.7 mg/dL which was considered high. Office notes of 23-JUN-2008 reported the patient experienced trembling while sleeping and dry skin. On 22-JUL-2008 the patient underwent a barium swallow. The patient was administered barium contrast orally. There was free flow of contrast through the esophagus and into the stomach. No abnormal strictures or abnormal extrinsic impression on the esophagus was seen. There was no gastroesophageal reflux seen during fluoroscopic examination. The stomach appeared normal. Duodenojejunal was in normal location without evidence for malrotation. On 22-AUG-2008 physician's notes reported a diaper rash x 1 week and noted the patient was spitting up formula. The patient was on an unspecified medication for gastroesophageal reflux disease (GERD). The physician's assessment was acute gastroenteritis. The physician treated the patient with NYSTATIN. On 08-SEP-2008 the patient was seen for follow up of the diarrhea and rash and was asymptomatic. The patient was noted to be on no medications. On 08-OCT-2008 the patient experienced rash over body/rash buttock/groin, times 1 week. The physician assessment was diaper rash that was probable Candida. NYSTATIN treatment was prescribed for the diaper area. At the time of reporting, the outcomes were unknown. This is one of several reports received from the same source. Additional information has been requested.
Hives shows up in various parts of body including face, neck, arms, back, scalp in the form of itchy red welts.  They disappear when Benadryl or Zyrtec are administered but reppear when medication wears off.
Fever 101, ankle swelling, all over body pain, pain in legs, hard to walk, weight loss 30 lbs in five months. Took TWO years to recover. Had to apply for short term medical leave, out of work for a month. Had Shingrix vaccine same day.
Provider ordered Dtap, nurse gave Kinrix. Patient's mother was called with med error. Patient not having any adverse reactions at this time.
Covid Arm . 8-10 inch light red, itchy rash extending equally up and down arm from injection site.
Swollen big toe and joint; Big toe, right foot, that joint has just got so swollen and tender and there has been real bad pain; Swollen big toe and joint; Big toe, right foot, that joint has just got so swollen and tender and there has been real bad pain; Swollen big toe and joint; Big toe, right foot, that joint has just got so swollen and tender and there has been real bad pain; Swollen big toe and joint; Big toe, right foot, that joint has just got so swollen and tender and there has been real bad pain; This is a spontaneous report from a contactable consumer (patient).  A 58-year-old male female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number: unknown), via an unspecified route of administration on 11Mar2021 (at the age of 58-years-old) as dose 1, single for covid 19 immunization. The patients medical history and concomitant medications were not reported. Reporter stated that he received a Pfizer vaccine shot on 11Mar2021. The only thing he had with the actual shot was stuck with the needle in it and he didn't feel any fever, no chills, no headache, nothing in the whole week. But exactly one weeks later, patient guessed and stated that on 18Mar2021, he did get a swollen big toe and joint and he looked it up, it looks like a gout. Patient had big toe, right foot, that joint had just got so swollen and tender and there had been real bad pain. Patient received aleve which was Naproxen and also, he had been taking Ibuprofen, over the counter for the treatment of events reported. Reporter further stated that he never had this before and queried for what should he be doing to alleviate his pain. The outcome of events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
After the shot at 430 pm, arm was sore that night. The next day, it was extremely sore and two inch round dark red area. I have a picture if can send, if that is possible.  About mid day extreme body aches. Headache, middle back kidney area. Mid afternoon prickly feeling, then red flushing on cheeks, jaw, neck and chest. Temperature, finally took it mid afternoon and it was near 102. Went to pharmacy clinic at 5 but they would not see me because they closed at 530 and would not see another patient. Pharmacist told me it would be ok to take two Benadryl. which I did at approximately 530. It relieved the flushing hives somewhat. That said, I had racing fast heart rate, and my oxygen was 88 to 92 all that evening. I had a pulse oxygen reader from when I had had covid in January 22, which is how I know the oxygen level was low.  Note, I would have gone to urgent care, but all Urgent Care facilities were closed on that Saturday evening!
This is a spontaneous case initially received from other health professional on 10-Apr-2019, concerning a male neonate patient. The patient's mother did not have any history of offspring (3 previous full-term live births reported) with major congenital malformation. The patient's mother had no maternal or paternal history with major congenital malformations. The patient's mother did not have a prior history of use of tobacco, alcohol or illicit drugs during pregnancy. The patient's mother risk factor included advanced maternal age. The patient's mother's last menstrual period (LMP) date was 08-Apr-2018. The patient's mother had singleton type of pregnancy. On 01-Jun-2018, patient's mother underwent ultrasound examination and no congenital malformation was noted. On 25-Jun-2018, a repeat ultrasound was performed, and no congenital malformation was noted. On 16-Jul-2018, Materni-T 21 genetic test and nuchal translucency test was performed, and no congenital malformation was noted. On 19-Oct-2018, at gestational age of 26 weeks, the foetus was exposed to AFLURIA QUADRIVALENT    (batch number: YF40208, route of administration: transplacental, dose, expiry date and anatomical location: not reported) (explicitly coded as foetal exposure during pregnancy) for an unknown indication. The patient's mother's estimated date of delivery (EDD) was reported as 13-Jan-2018 and corrected EDD was reported as 22-Jan-2019. 3 months and 6 days after vaccination (at the gestational age of 39 weeks), a male patient was born with large for gestational age, body weight 3670 g, head circumference: no data and length: no data, Apgar score at one minute was 8 and at 5 minutes was 9 and no data at 10 minutes and delivery method: caesarean. The patient's mother pregnancy complication included large for gestational age. On an unspecified date in 2018, patient's mother's early 1-hour glucose test was performed which showed elevated values. The outcome of the event large for gestational age was not reported. This case is linked to case 201805222 (mother case).; Reporter's Comments: A male neonate born with large for gestational age (body weight 3670 g), 3 months and 6 days after receipt of AFLURIA QUADRIVALENT vaccine administered to mother at approximately 26 weeks of gestation. Considering the risk factors (advanced maternal age, multigravida, gestation age at birth-39 weeks and elevated early 1-hour glucose test) and no evidence for a biological mechanism that could cause the event, the event was assessed as not related to the suspect vaccine. The decision to administer a vaccine during pregnancy is related to medical decision making by the mother and her physician and is not related to any property of the medication. The event of foetal exposure during pregnancy was assessed as not related considering the intended use of the vaccine.The company assessed the case as serious (medically significant).
day of vax pt exp irritability, consolable but difficult, swelling at inject site, fever 99f
Mild Headache within 2 hours of injection, that was gone by next morning.  One day after the shot, woke to arm pain at injection site, and had mild muscle/joint pain (specifically on my left hand & hips). On morning of day 2, stomach cramping & diarrhea (large quantity & foul odor), arm pain at injection site continued.
mom states p/shot both eyes swollen lumps size nickel on forehead, rash (hives??) on neck & some abd; no fever ER;
Mother called our office on 8/24/04 to report chicken pox. Child developed rash evening of 8/23. Had approx 40 lesions on trunk, head, face, and genitals. Lesions described as red dots with fluid filled blisters. Temp 99 on 8/23 afebrile after that. Sibling was seen in our office on 8/12/2004 with modified varicella post immunization.
This non-serious initial spontaneous case, was received from Other Non-Health Professional on 02-Nov-2017, concerning a 76-year-old female patient. The patient's medical history included: she usually gets some induration on the injection site when she receives the flu shot. The patient's concomitant medication included: Omega 3 started 1 week before the shot, FOSAMAX and unspecified vitamins. On 23-Oct-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number, expiry date: not reported). On the same day, the patient had a pinkish rash across her arm without pain for the first night. After a week her arm turned black and blue then yellow and finally it turned purple. It was reported that the patient's arm was clear on one side but had U shape of a bruise. At the time of this report, the patient had not yet recovered from the events (reported as arm was purple). The reporter assessed the event as non-serious.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. On 10-JUL-2017, the patient was inadvertently vaccinated with expired dose of ZOSTAVAX lot # M015926, expiration date: 28-JUN-2017. No adverse effects were reoprted.
received an unspecified HPV vaccine and became pregnant; received an unspecified HPV vaccine; This spontaneous prospective pregnancy report was received from a consumer referring to her friend, a female patient of unknown age. The patient's relevant medical history, drug reactions/allergies and concomitant medication were not reported.     On an unknown date, the patient was vaccinated with an HPV vaccine (unspecified if hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) or hpv rl1 6 11 16 18 vlp vaccine (yeast)) for prophylaxis (strength, route, dosage schedule, lot number and expiration date were not reported).    On an unknown date after vaccination, the patient became pregnant. The last menstrual period (LMP), estimated date of conception and estimated date of delivery (EDD) were not known and could not be calculated. The pregnancy outcome was pending and the fetal outcome was unknown.
This spontaneous report as received from a nurse practitioner refers to a 4 year old male patient. On 25-MAY-1995, the patient was vaccinated with first 0.5 ml dose of M-M-R II (lot # not reported) subcutaneously in the left posterior lateral arm. On 26-AUG-1998, the patient received the second 0.5 ml dose of M-M-R II (lot # not reported) subcutaneously and on 25-AUG-2014, the patient received a third 0.5 ml improperly stored booster dose of M-M-R II (lot # not reported) subcutaneously. No adverse effects were reported. Additional information has been requested.
Dizziness, Headache, Myalgia, Arthralgia, felt warm, injection site pain Narrative:  The morning after receiving the second dose of the vaccine, the patient reported feeling warm and dizzy while having body aches, injection site pain, and a headache. She denies seeking any treatment.
Information has been received from a licensed practical nurse concerning a 19 year old female with no pertinent medical history and no drug reactions/allergies, who on 12-JUN-1989 was vaccinated with at least one dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). There was no concomitant medication. On 13-AUG-2007, lab diagnostics studies performed showed that the patient has negative titers for rubella. No symptoms have been reported. No further information is available. The outcome is unknown. Unspecified medical attention was sought. There was no product quality complaint. Additional information has been requested.
Slight fever started within 3 hours.  98.4 (97.1 is normal for patient). Next morning(4/15)  unable to balance and put on pants without help.  left foot caught on steps when walking downstairs.  Walked with a slight limp.  Later in the day 1PM 0n 4/15 handwriting started to become sloppy.  patient writes with left hand and wasn't able to lift pen off paper when writing.  Slight difficulty walking.  tendency to stumble over left foot.  Saturday morning 4/17 9 AM, numbness in left hand.  Unable to hold shoe in hand.  Unable to tie shoe laces.  Nurse came to home for a neurological test and noted patient is weaker on left side.    Occular migraine began.
unable to lift arm for several hours; SEVERE shoulder pain; decreased range of motion which has persisted for 3 months now; This is a spontaneous report from a contactable consumer (patient). A 59-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Batch/Lot Number: ER8733), dose 1 via an unspecified route of administration, administered in Arm Left on 31Mar2021 at 13:15 (at the age of 59 years) as dose 1, single for COVID-19 immunisation. The patient medical history was not reported. Concomitant medication(s) included acetylsalicylic acid (BABY ASPIRIN); vitamin d nos (VITAMIN D NOS). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 01Apr2021 at 07:00, Patient reported within 24 hours, unable to lift arm for several hours, followed by severe shoulder pain and decreased range of motion which has persisted for 3 months now. Patient received Physical therapy as a treatment for events. The adverse event resulted in Doctor or other healthcare professional office/clinic visit. The outcome of events was not recovered.
Right arm hurts dwon to her fingers. Arm has been very sore for three days. Patient did go see her Dr. on 10/21/2010 and gave her a cortisone shot in the area of the injection site. Will see Dr. agin in three weeks or to call if not better will do an EMG if not improved. Patient was going to go see the orthopedic on 11/11/2010 and will call back when she know more. Patient has not called back with results.
HYPOTENSION 2/5/2023 ARTHRITIS  HYPOXEMIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY 1/16/2023 ARTHRITIS  HYPOXEMIA 12/5/2022 ARTHRITIS
Pt c/o body rash 6-7 days after receiving small pox vaccine. Currently rash is on anterior trunk, arm, thighs and neck. Rash is itchy, and itchiness increase when PT is visit. PT seen was given BENADRYL.
Symptoms consistent with a mild case of bell's palsy. Numbness and tingling in left side of face from chin to cheekbone. No drooping in mouth or eye
Was fine until a week and a half later the site of inj. started to itch and was red...uncomfortable to the touch It has been 3 days now and it seems like the area is larger....will apply a cold compress and draw the area to see if tomorrow has expanded
I developed hives all over my body after receiving vaccination and had them everyday until seeking medical attention.  I was diagnosed with chronic urticaria and angioedema in August 2021.  I have to receive Xolair injections every 4 weeks to prevent hives as well as taking Zyrtec
extra sore after second shot; This is a spontaneous report from a contactable consumer or other non hcp (patient's Wife). A male patient of an unspecified age received BNT162B2, (COMIRNATY, solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as 2nd dose, single for covid-19 immunisation.  The patient medical history and concomitant medications were not reported.  The patient experienced extra sore after second shot on an unspecified date. It was also reported that Her other kids and her husband and herself all felt extra sore after the second shot. The Outcome of the event was unknown.    Information on the lot/batch number has been requested .
Itching and hives that started on lower legs and spread upward.  Swelling of eyes and lips. Patient self treated with Benadryl p.o.
Dec 18 & 19: 101-102 F fever + swollen lymph nodes under left armpit size and shape of a mango + pain radiating in left chest and behind left shoulder blade + spike in blood pressure (140/90+) Dec 20: blood pressure rising: 150/high 90 Dec 21: blood pressure rising: 160/103 Dec 22: lymph nodes reduced in swelling but replaced by bruising (yellow/greenish in color).  blood pressure normal Dec 24: still some swelling and bruising appearance.  blood pressure normal
Nagging cough; Tickle in my throat; I go hoarse really easily; I was sick for about 3 days after the booster; Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Nagging cough), OROPHARYNGEAL DISCOMFORT (Tickle in my throat), DYSPHONIA (I go hoarse really easily), ILLNESS (I was sick for about 3 days after the booster) and PYREXIA (Fever) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 01-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Nov-2021, the patient experienced COUGH (Nagging cough), OROPHARYNGEAL DISCOMFORT (Tickle in my throat), DYSPHONIA (I go hoarse really easily), ILLNESS (I was sick for about 3 days after the booster), PYREXIA (Fever) and CHILLS (Chills). At the time of the report, COUGH (Nagging cough), OROPHARYNGEAL DISCOMFORT (Tickle in my throat) and DYSPHONIA (I go hoarse really easily) had not resolved and ILLNESS (I was sick for about 3 days after the booster), PYREXIA (Fever) and CHILLS (Chills) had resolved.            No concomitant medication was reported.  No treatment medication was reported.
CRP was normal at 1.9 on 1/25.  Vaccine given 1/27 and CRP checked on 1/29 due to fever was elevated at 6.97.  Recheck of CRP on 1/30 was still elevated at 7.33.  Fever and elevated CRP ultimately attributed to vaccine, with no other signs of infection present.
Patient had fevers and hearing loss the day after administration of the vaccines. I saw her 1 week after and she still had left hearing loss.